Navigation Links
Next Generation Proton Therapy System for Cancer Treatment Set for Release This Year
Date:2/26/2009

LITTLETON, Mass., Feb. 26 /PRNewswire/ -- Still River Systems announced today the successful operation of the world's highest field, high energy cyclotron magnet. Still River's magnet is the key technical element for reducing the size and cost of the particle accelerator that will deliver proton therapy at a number of hospitals beginning with the first installation at Barnes Jewish Hospital in St. Louis, Missouri this fall.

"The last six months have been very exciting," said Marc Buntaine, CEO. "Still River has achieved all of the component milestones that bring us to system integration and delivery." Proton therapy, widely regarded as the next evolutionary step in the radiation treatment of cancer, has seen unprecedented interest from the radiation oncology and patient communities in recent years. However, the large size and high cost of existing proton therapy systems have made it difficult for the average hospital to add this powerful tool to their cancer fighting arsenal.

The heart of the Monarch250, a superconducting magnet developed in an industrial and academic partnership with the Massachusetts Institute of Technology, has now tested operational and stable at its full design current "This magnet sets a record for magnetic field strength used in a high energy cyclotron. The cyclotron built around this magnet will be the most compact source for proton therapy available today." said Dr. Kenneth Gall, founder and Chief Technology Officer. "All of the Monarch250 sub-systems are now in the final phases of manufacturing and will be ready to ship to our first customers for installation later this year".

Still River's Monarch250 proton therapy system, a unique and compact machine, was developed to provide proton therapy at a greatly reduced cost and size. In addition, Still River Systems has incorporated the latest advancements in radiation therapy patient management with its innovative accelerator technology, including a robotic couch for patient positioning, dedicated proton therapy treatment planning, cone beam CT imaging, and motion management. All of these clinical systems have been integrated within the Monarch250 platform. "Our goal is to provide our customers with a fully integrated, turnkey proton therapy solution with the most advanced clinical systems for patient management" said Dr. Skip Rosenthal, Vice President of Clinical Systems. "Integrating these key radiation therapy technologies is critical to ease of use in a clinical setting."

Still River Systems first installation sites, Barnes Jewish Hospital in St. Louis, Missouri and Robert Wood Johnson University Hospital in New Jersey, have begun construction for the new facilities that will house the first Monarch250 systems in the United States.

Still River Systems, based in Littleton, Massachusetts, is dedicated to providing physicians and their patients' access to high quality, cost-effective proton therapy solutions. Still River Systems is developing the Monarch250, an affordable, precise and compact proton therapy system for cancer treatment. This system has not yet been cleared by the FDA for commercial use in clinical therapy. For more information on Still River Systems and the Monarch250 Proton Therapy System, please call 978-540-1500 or visit www.StillRiverSystems.com.


'/>"/>
SOURCE Still River Systems
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
2. Pieris Reports Development Progress for Anticalin(R) PRS-050, a Next Generation VEGF Antagonist
3. Inclinix Releases Next Generation Critical Population Research(R) (CPR) for Clinical Trial Investigator Site Selection and Patient Recruitment
4. Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix
5. Medarex Announces Enhanced Activity Data with Second Generation Anti-CD30 Antibody for Malignant Lymphoma
6. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
7. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
8. Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientifics Next-Generation Taxus Liberte Stent
9. Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
10. Stem Cell Regeneration Repairs Congenital Heart Defect
11. TOZAL(R) Nutritional Supplement Improves Vision in Common Form of Macular Degeneration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)...  BTL Aesthetics today announced the release of ... ME device was effectively redesigned for more efficient, ... tissue. The result: Significantly better outcomes in abdominal ... ME versus BTL Vanquish. "We are ... patients with the most highly-advanced devices on the ...
(Date:12/6/2016)... 6, 2016  Arcturus Therapeutics, Inc. ("Arcturus" or ... today that it entered into collaboration with Takeda ... the treatment of NASH and other gastrointestinal (GI) ... LUNAR™ and UNA Oligomer chemistry. The financial terms ... commitment to and expertise in GI disorders, we ...
(Date:12/6/2016)... 6, 2016 A new study released today ... 340B) projects the 340B Drug Pricing Program will continue to ... it is expected to exceed $23 billion in total purchases ... purchases surpass current Medicare Part B drug reimbursement purchases over ... – based on analysis of data on total drug purchases ...
Breaking Medicine Technology:
(Date:12/7/2016)... , ... December 07, 2016 , ... "Hacking into my ... had described him as 'a genius.'" Thus begins "Margaret in Berlin," Book Twelve in ... published by Wyston Books, Inc. These novels narrate the lives of a ...
(Date:12/6/2016)... ... December 06, 2016 , ... Men with gum ... risk of serious health problems, such as cardiovascular illness, according to research cited ... Beverly Hills Periodontics & Dental Implant Center notes that the correlation between periodontal ...
(Date:12/6/2016)... ... ... An inventor, from Talladega, Ala., thought there needed to be a more ... , The SLING-VEST provides an effective way to support and align the arm or ... result, it helps to reduce discomfort and shifting. The invention features an effective design ...
(Date:12/6/2016)... ... ... Mount Sinai Health System today announced the creation of the Medical Modeling ... order 3D models for their cases. Virtual reality, simulation, and 3D printing services ... resource will be the first of its kind catering to the unique patient-specific modeling ...
(Date:12/6/2016)... Scottsdale, Arizona (PRWEB) , ... December 06, 2016 , ... ... less than fIve days after launch. Almost 200 backers pledged more than $25,000 ... life-changing technology. , Dr. Amy Serin, an Arizona Neuropsychologist and inventor, ...
Breaking Medicine News(10 mins):